patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: I really hope we continue to see a slow, controlled rise in share

price. I don't believe we want to become a daytrader's dream by having lots of volume and large fluctuations in price. Although I would also add that because the float is so small when this baby does lift off it could really go fast. FDA approval will send us soaring and the daytraders had better watch this backside because it could get really crazy. Definitely not a stock I would want to try to short.

Share
New Message
Please login to post a reply